Biotecnología

Biotecnología

EPNextS Group and Frontage Labs Partner to Address ‘Drug Lag’ & ‘Drug Loss’ in Japan
27/03/2024 - Aim to combine their respective strengths to streamline the drug development process and bring novel treatments to market more efficiently.
Veeda Clinical Research Acquires European CRO, Heads
27/03/2024 - Expands Veeda’s global reach and adds capabilities for contract research services from discovery to clinical development and post commercial launch.
Exothera Launches Nucleic Acids Service Offering Powered by Ntensify
27/03/2024 - Continuous batch production of RNA service significantly cuts clinical development time while enhancing quality and yield.
AstraZeneca’s Ultomiris Approved by FDA for the Treatment of Adults with NMOSD
27/03/2024 - Long-acting C5 complement inhibitor offers patients with AQP4 Ab+ NMOSD the potential to live relapse-free.
BioNTech Faces NIH Heat: Notice of Default Issued Over COVID-19 Vaccine Royalties
27/03/2024 - BioNTech intends to vigorously defend itself against all allegations of breach.
Ex-Prometheus Executives Launch Mirador Therapeutics
26/03/2024 - Aims to revolutionize precision medicine for immune-mediated inflammatory and fibroitic diseases.
Italfarmaco S.p.A.’s Duvyzat Approved by FDA
26/03/2024 - Orally administered treatment for Duchenne muscular dystrophy approved in patients 6 years and older.
Olon Celebrates 10 Years of Daptomycin
26/03/2024 - Doubles its production capacity to meet global demand for the active ingredient.
Johnson & Johnson’s Nipocalimab Earns Breakthrough Therapy Designation from FDA
26/03/2024 - Phase 3 clinical trial enrollment is underway.
AbbVie’s ELAHERE Granted Full Approval by FDA for Ovarian Cancer
26/03/2024 - Full approval was based on data from the confirmatory Phase 3 MIRASOL trial.
Altamira, Univercells Partner on Nanoparticle-Delivered mRNA Vaccines
26/03/2024 - Univercells will test in vitro and in vivo a proprietary mRNA vaccine delivered with Altamira’s SemaPhore nanoparticle platform.
Andelyn Biosciences Partners with Grace Science to Advance GS-100
26/03/2024 - Will tech transfer Phase I/II/III manufacturing of the suspension process adeno-associated virus (aav) gene therapy for NGLY1 deficiency.
Novo Nordisk Agrees to Acquire Cardior Pharmaceuticals
26/03/2024 - Strengthens its pipeline of projects in cardiovascular disease with Cardior’s lead compound CDR132L.
AbbVie Agrees to Acquire Landos Biopharma
26/03/2024 - Aims to advance the clinical development of NX-13, a differentiated, first-in-class, oral asset.
BMS Completes $14B Acquisition of Karuna Therapeutics
24/03/2024 - Adds KarXT, a potential first-in-class treatment for schizophrenia with potential across multiple indications.
Qosina Names David Oh to Represent Korean Market
24/03/2024 - David brings more than two decades of experience to his new role.
Samsung Life Science Fund Invests in BrickBio
24/03/2024 - Samsung affiliates will work with BrickBio to evaluate, manufacture, and develop therapies using BrickBio's protein engineering technology.
Idorsia’s TRYVIO Approved by FDA for the Treatment of Hypertension
24/03/2024 - Idorsia plans to make TRYVIO available to the millions of patients in the US who are not controlled on other drugs in the second half of 2024.
Selvita Adds Antibody Discovery and Development Capabilities
24/03/2024 - Will open a new research site in Wroclaw, Poland, with over 400 square meters of state-of-the-art labs along with all necessary infrastructure.
Batavia and Candel Partner to Accelerate Development of CAN-3110
24/03/2024 - Aim to advance and accelerate the development of treatments for recurrent high-grade glioma.
BioNTech 4Q Earnings Hit by Drop in Covid Vax Sales
24/03/2024 - Inventory write-downs by partner Pfizer reduced revenues by €291.3 million in the quarter and €906.7 million for the year.